SFJ Pharmaceuticals’ Acquisition of Bentracimab Assets

Martina Bellini
Tagged:

Orrick advised SFJ Pharmaceuticals on the deal.SFJ Pharmaceuticals (“SFJ”) announced its acquisition of assets related to Bentracimab, a drug with the potential to address a significant unmet…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now